Topper David Joseph
SEC CIK 1740378 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | CFO | 182.8K | — | $261.9K | 5 | 2024-04-10 | 2025-04-02 |
Most active insiders at ARQT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watanabe Todd | See Remarks, Dir | — | $5.32M |
| 2 | Welgus Howard G. | Dir | — | $2.43M |
| 3 | Matsuda Masaru | See Remarks | — | $2.21M |
| 4 | Burnett Patrick | See Remarks | — | $2.02M |
| 5 | Leonard Keith R | Dir | — | $997.1K |
| 6 | Curran Terrie | Dir | — | $984.0K |
| 7 | Edwards Larry Todd | See Remarks | — | $968.4K |
| 8 | Krishnamohan Neha | Dir | — | $939.5K |
| 9 | LIN SUE-JEAN | Dir | — | $898.5K |
| 10 | Gilbert Halley E | Dir | — | $455.5K |
Topper David Joseph made no open-market trades at ARQT in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-03 | 2025-04-02 | ARQT | Arcutis Biotherapeutics, Inc. | Topper David Joseph | CFO | S - Sale | $15.80 | -9,600 | 182.8K | -5% | -$151.7K | |
| D | 2025-03-04 | 2025-02-28 | ARQT | Arcutis Biotherapeutics, Inc. | Topper David Joseph | CFO | A - Grant | $0.00 | +34.0K | 192.4K | +21% | $0 |
| 2024-09-25 | 2024-09-24 | ARQT | Arcutis Biotherapeutics, Inc. | Topper David Joseph | CFO | S - Sale | $9.48 | -11.6K | 158.4K | -7% | -$110.2K | |
| 2024-09-25 | 2024-09-21 | ARQT | Arcutis Biotherapeutics, Inc. | Topper David Joseph | CFO | A - Grant | $0.00 | +60.0K | 170.0K | +55% | $0 | |
| D | 2024-04-11 | 2024-04-10 | ARQT | Arcutis Biotherapeutics, Inc. | Topper David Joseph | CFO | A - Grant | $0.00 | +110.0K | 110.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations